Dermatology Research and Practice is a premier open access journal published by HINDAWI LTD, dedicated to advancing the field of dermatology since its establishment in 2009. With a respectable impact factor and a ranking of #42 out of 142 in the Scopus Medicine - Dermatology category, the journal stands in the 70th percentile, reflecting its influence and relevance in contemporary dermatological research. Based in Egypt, it provides a platform for groundbreaking studies that shape clinical practice and policy worldwide. The journal covers a wide range of topics within dermatology, including but not limited to clinical research, epidemiology, and patient care, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding and contribute to the field. Emphasizing open access, Dermatology Research and Practice ensures that vital research findings are readily available to the global community, fostering collaboration and innovation in dermatology.

Australasian Journal of Dermatology is a leading publication in the field of dermatology, issued by Wiley since 1951, and reaching an audience of researchers, clinicians, and students interested in the latest advancements and practices in skin health. With an ISSN of 0004-8380 and an E-ISSN of 1440-0960, this journal stands out with its Q2 ranking in both Dermatology and Miscellaneous Medicine, positioning it within the top 61st percentile of its category according to Scopus. Although it does not provide Open Access options, Australasian Journal of Dermatology is committed to disseminating high-quality research that informs clinical practices and promotes scholarly dialogue. By publishing rigorous and peer-reviewed articles focused on various aspects of dermatological science, the journal plays a pivotal role in enhancing the dermatology community's understanding of skin conditions and treatments, making it an invaluable resource for professionals and students alike.

CLINICAL AND EXPERIMENTAL DERMATOLOGY is a prominent journal in the field of dermatology, published by Oxford University Press. With an ISSN of 0307-6938 and an E-ISSN of 1365-2230, this journal has been a vital resource for researchers and practitioners since its inception in 1976. Recognized as a Q2 journal within the category of dermatology for 2023, it holds a respectable position, ranking #54 among 142 journals in this discipline, placing it in the 62nd percentile on Scopus. The journal is dedicated to publishing high-quality research that spans clinical and experimental aspects of dermatological science, making it an essential source of knowledge for advancing understanding and treatment of skin disorders. Although it operates on a traditional subscription model without open access options, its contributions to the field are significant, influencing both clinical practices and academic research. Researchers, clinicians, and students alike will find vital insights and contemporary themes presented in its pages, supporting ongoing education and innovation in dermatology.

The Journal of Dermatology, published by Wiley, is a premier academic journal dedicated to advancing the field of dermatology, with its esteemed reputation reflected in its Q1 ranking in Dermatology and a remarkable Q2 ranking in Miscellaneous Medicine as of 2023. Since its inception in 1974, the journal has become a vital resource for researchers, clinicians, and students alike, covering pioneering studies and cutting-edge advancements in skin health and disease. With a Scopus rank of #32 out of 142 in the Dermatology category, placing it in the 77th percentile, the journal underscores its commitment to fostering knowledge and innovation within the dermatological community. Although the journal operates under a subscription model, it remains an essential platform for disseminating impactful research that shapes clinical practice and enhances patient care. For anyone invested in dermatological sciences, Journal of Dermatology serves as a key publication where critical insights and developments are regularly showcased.

SKIN PHARMACOLOGY AND PHYSIOLOGY is a leading peer-reviewed journal published by KARGER, based in Switzerland, that focuses on the intricate interplay between skin pharmacology and physiology. With its ISSN 1660-5527 and E-ISSN 1660-5535, the journal spans a rich history of publication since 1988, presenting groundbreaking research and discoveries in the fields of dermatology, pharmacology, and physiology. As evidenced by its 2023 quartile rankings, which include Q2 in Dermatology and Q2 in Medicine (miscellaneous), this journal is highly regarded, ranking in the 83rd percentile for dermatology in Scopus, reflecting its significant impact on the scientific community. Researchers, professionals, and students alike will find valuable insights in this publication, which aims to disseminate knowledge and foster innovations that enhance the understanding of skin-related health. The open access policies provide wider accessibility to relevant findings and developments, making it an essential resource for anyone dedicated to advancing the field.

Skin Appendage Disorders, published by KARGER, is an esteemed academic journal focusing on the intricate realm of dermatology, particularly the structure and function of skin appendages. Established in 2016 and projected to continue through 2024, this journal has swiftly gained recognition, securing a respectable Q2 ranking in the field of Dermatology as of 2023, and achieving a Scopus rank of 76 out of 142 in the same category. With an ISSN of 2296-9195 and an E-ISSN of 2296-9160, the journal presents a platform for innovative research and clinical findings that address the multifaceted aspects of skin appendage disorders. Researchers, practitioners, and students will find significant value in its open access model, which encourages widespread dissemination of knowledge and fosters collaboration within the dermatological community. By publishing high-quality peer-reviewed articles, Skin Appendage Disorders aims to elevate the understanding of dermatological conditions and contribute to advancements in therapeutic practices, making it a vital resource for those dedicated to skin health.

The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

Dermatologie, published by SPRINGER HEIDELBERG, is a prominent journal dedicated to the advancing field of dermatology. With its ISSN 2731-7005 and E-ISSN 2731-7013, this journal has established itself as a valuable resource for researchers, professionals, and students alike. Originating in Germany, the journal focuses on disseminating innovative research from 2022 to 2024, contributing significantly to the understanding of skin health and disease management. Despite its current ranking within the Q3 category in dermatology and a Scopus rank of #88/142, it provides critical insights and advances in clinical practice, epidemiology, and therapeutic modalities. With an emphasis on open discourse, it seeks to foster collaboration among healthcare professionals and researchers, thereby enhancing the quality and accessibility of dermatological research. Engage with Dermatologie to stay at the forefront of the latest advancements in skin-related health issues.

Dermatologica Sinica, published by Wolters Kluwer Medknow Publications, is an esteemed open-access journal in the field of dermatology that has been disseminating critical research since its inception in 2005. With an E-ISSN of 2223-330X and an ISSN of 1027-8117, this journal presents a platform for researchers, clinicians, and students to share cutting-edge findings and advancements in dermatological science. As of 2023, it proudly ranks in the Q2 category of dermatology journals and holds a notable position at rank #62 out of 142 in the Scopus Medicine - Dermatology category, placing it in the 56th percentile for impact. The journal transitioned to an open-access model in 2016, enhancing accessibility and visibility for groundbreaking studies worldwide. With a commitment to fostering innovation in the dermatological community, Dermatologica Sinica aims to advance the understanding and treatment of skin diseases while encouraging scholarly dialogue among practitioners and researchers across the globe.

Turkderm - Turkish Archives of Dermatology and Venerology, published by GALENOS PUBL HOUSE, serves as a vital platform for the dissemination of innovative research and advancements in the fields of dermatology and venerology. With an Open Access policy implemented since 2002, this journal aims to provide free and unrestricted access to significant findings, ensuring that vital information reaches a global audience. Based in Turkey, the journal has positioned itself as an important resource for professionals, researchers, and students alike, despite currently being categorized in Q4 of both Dermatology and Infectious Diseases as per the 2023 metrics. Although it faces competition in the rankings, with a Scopus standing of #131 in Dermatology and #331 in Infectious Diseases, its dedication to advancing knowledge in these critical health areas is unwavering. The journal continually invites original research, reviews, and case studies that enhance clinical practices and foster understanding in the dermatological community.